MRI-TRUS Fusion Prostate Biopsy
An MRI-TRUS fusion biopsy overlays your prostate MRI onto live ultrasound, creating a 3D map so the urologist can guide the needle straight into suspicious lesions. Compared with older systematic biopsies, this targeted approach improves detection of significant cancers while reducing sampling of harmless ones. It is usually a day-case procedure.
Medically reviewed by the Florence Healthcare medical team · Last reviewed June 2026
Overview
An MRI-TRUS fusion biopsy is a targeted way to sample the prostate for cancer. You first have a multiparametric MRI (mpMRI), which highlights any suspicious areas and scores them on the PI-RADS scale. During the biopsy, that MRI is digitally fused with live transrectal ultrasound so both images overlay in real time, producing a 3D map of the gland. This lets the urologist direct the needle precisely into the flagged lesion, rather than sampling the prostate in the random grid pattern used by older systematic biopsies, which can miss meaningful cancers or over-detect insignificant ones.
From your first enquiry, a dedicated international patient coordinator manages your journey end to end. Before you travel, our urologists can carry out a remote second-opinion review of your existing mpMRI images and PSA results to confirm whether a fusion biopsy is the right next step, and you receive a transparent, itemized cost estimate after that review so there are no surprises on arrival.
Who is a candidate?
- A raised or steadily rising PSA blood test
- An abnormal area felt during a digital rectal examination
- A suspicious lesion identified on multiparametric MRI (PI-RADS 3-5)
- Men on active surveillance for low-risk prostate cancer who need a planned re-biopsy
- A previous negative systematic biopsy despite ongoing clinical suspicion
- Fitness for a short day-case procedure under local or general anaesthesia, confirmed at assessment
What happens
- 1
Multiparametric MRI first
If you have not already had one, you undergo a multiparametric MRI of the prostate. A radiologist marks any suspicious areas and assigns a PI-RADS score, which becomes the roadmap for the biopsy.
- 2
Fusion & planning
On the day, your MRI is uploaded and digitally fused with live transrectal ultrasound. The system aligns the two images into a 3D model, and the urologist plans the exact needle path to each target.
- 3
The biopsy
Using the fused image for guidance, a few small tissue cores are taken from the targeted lesions, often with a small number of additional systematic samples. It can be done transrectally or transperineally, usually under local anaesthetic with sedation or short general anaesthesia.
- 4
Results & next steps
The cores are sent to pathology. Your coordinator shares the report once ready, and your urologist explains the findings and discusses whether treatment, further monitoring, or no action is appropriate.
Benefits
- More accurate targeting of suspicious lesions seen on MRI
- Better detection of clinically significant cancers that grid biopsies can miss
- Fewer needle cores needed compared with extensive random sampling
- Helps avoid over-detecting low-risk cancers that may never need treatment
- Supports precise monitoring for men on active surveillance
- Usually a day case, allowing a same-day return home
Risks & considerations
- Blood in the urine, semen, or stool for a short period afterwards, which usually settles on its own
- Risk of urinary tract infection, lower with the transperineal approach
- Temporary difficulty or discomfort passing urine, occasionally needing a short-term catheter
- Soreness or bruising around the biopsy site
- As with any biopsy, a small chance that a cancer is not detected, which is why follow-up matters
- Reactions to anaesthesia or sedation, discussed with you beforehand
Conditions this treats
Learn more before you decide
Provider-reviewed guides on the related conditions, symptoms and tests in our Health Library.
MRI-TRUS Fusion Prostate Biopsy — frequently asked questions
A standard systematic biopsy samples the prostate in a set grid pattern without seeing where cancer may be, so it can miss significant tumours or pick up harmless ones. A fusion biopsy uses your MRI to aim the needle directly at suspicious lesions, which generally improves detection of clinically significant cancer while reducing unnecessary sampling. Many men also need fewer cores.
Yes. The multiparametric MRI is what makes the procedure targeted. It identifies and scores suspicious areas that are then fused with live ultrasound to guide the needle. If you already have a recent mpMRI, we can often use it; if not, one is arranged before the biopsy.
Transrectal means the needle passes through the rectal wall; transperineal means it passes through the skin behind the scrotum, which carries a lower infection risk. Both are usually done as a day case under local anaesthetic with sedation, or a short general anaesthetic, so you should feel little or no pain during the procedure. Mild soreness afterwards is normal.
After our team reviews your MRI and PSA, you receive a transparent, itemized cost estimate covering the imaging, procedure, anaesthesia, and pathology, personalised to your case, so we never quote a price before understanding what you need. Pathology results are typically ready within several days, and your coordinator shares them as soon as your urologist has reviewed them.
Yes. You can securely send your existing mpMRI images and recent PSA results, and our urologists will carry out a remote second-opinion review to advise whether a fusion biopsy is appropriate and what to expect. This happens before you commit to travelling, alongside your personalised cost estimate.
Related treatments
Considering mri-trus fusion prostate biopsy?
Share your reports for a medical second opinion and a transparent, itemized cost estimate — usually within 48 hours.